Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.
Recombinant DNA technology has been central in answering some of the most relevant questions in the research of regulation of the functional status of hematopoietic progenitor cells and their progeny. This leading article will focus on recent results that have emerged from studies utilizing recombinant molecules that control hematopoietic blood cell development and activation. The following features will be detailed: The molecular and biological characteristics and biochemistry of hematopoietic growth factors, synergizing factors and releasing factors, their role in the regulation of hematopoiesis and activation of normal and leukemic cells, their cellular sources, and regulation of production.
Herrmann
F
F
Department of Hematology, Johannes Gutenberg-Universität, Mainz, Federal Republic of Germany.
Mertelsmann
R
R
D000818:Animals; D002478:Cells, Cultured; D006133:Growth Substances; D006410:Hematopoiesis / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D010455:Peptides
D006133:Growth Substances; D010455:Peptides